4pm BST (UK) / 5pm CEST (EU-Central)
Antimicrobial Resistance (AMR)
Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID Pandemic
In this webinar, AMR experts willl discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize the pipeline for antibacterial drugs. Key topics for discussion include:
- Antibiotics and AMR: drug development pre-pandemic, impacts from COVID-19, and visions for post-pandemic realities
- The importance of global antimicrobial resistance surveillance
- How global AMR surveillance programs and data mining of local and regional antibiograms can be leveraged to inform antimicrobial drug development and optimize clinical trials, for example in feasibility and site selection
- How can we continue the momentum, the passion, and awareness that was awakened by COVID-19 to other global threats like AMR?